Moving cannabis to a category of drugs that includes some common medicines will have implications for research, businesses ...

President Donald Trump has signed an executive order reclassifying marijuana from a Schedule I to a Schedule III drug under ...

Trump's executive order hastens a recategorization of marijuana from a Schedule I drug under the 1971 Controlled Substances ...

By the authority vested in me as President by the Constitution and the laws of the United States of America, it is hereby ordered: Section 1.  Purpose and ...

For the fifth year in a row, use of most substances among teenagers in the United States has continued to hover around the ...

A team of researchers, led by Lisa Marsch, PhD, at Dartmouth’s Geisel School of Medicine, has received a four-year $13-million grant from the National Institute on Drug Abuse (NIDA) to conduct the ...

Nick Padlo's addiction to alcohol and drugs didn't happen overnight. "I was using them as a tool to cope with depression and anxiety," says the recovered addict and founder of Sophros Recovery ...

The Food and Drug Administration granted accelerated approval on Wednesday for a new drug developed by researchers at the Broad Institute that treats non-small cell lung cancer — the most common type ...

ARIA, a Brown-based research consortium supported by a $20 million grant from the National Science Foundation, welcomed scientists from across the U.S. to kick off its five-year program with a launch ...

A staffer at the National Institutes of Health (NIH) who helped organize a letter critical of the Trump administration’s health leadership said she was put on administrative leave just as the federal ...

ABSTRACT: Guided by the Social Learning Theory, this conceptual review examines the prevalence, risk factors, and consequences of substance use among students, drawing on evidence from national ...